The State of Altered States

The State of Altered States

Actions and Detail Panel

$40

Date and time

Location

Webster Hall SF

2395 Sacramento Street

San Francisco, CA 94115

View map

Refund policy

Contact the organizer to request a refund.

Eventbrite's fee is nonrefundable.

Join us for a panel discussion & community event exploring current research, emerging clinical practice & the future of psychedelic medicine

About this event

The State of Altered States: Psychedelic Medicine and Mental Health Treatment

Friday, September 16th, 6:00 - 8:30pm Webster Hall, 2395 Sacramento St. San Francisco

Psilocybin, Ketamine, MDMA: The interest in psychedelics has exploded and research suggests a coming paradigm shift in how we think about mental health and treatment. While so much has been discovered about these medicines’ potential there is still so much to learn.

What does the current science and research tell us about how we, and our communities, might benefit from psychedelic therapies?

Access Institute’s founder and Executive Director, Bart Magee, Ph.D. will facilitate a panel discussion among experts in the field probing key questions:

  • What does the current research show about effectiveness?
  • How are psychedelics being used in clinical practice?
  • Where are we headed in science and in the culture?
  • And how might we ensure equitable access to promising treatments that are currently unaffordable to many?

The panel will also invite questions from the audience. Following the formal discussion will be a social hour where participants will have an opportunity to meet some of the leaders in the field.

We ask that all participants are vaccinated or show proof of a negative COVID test (within 24 hours). Audience members will be required to wear masks during the presentation. During the social portion of the event, masks will be optional.

Panelists:

Jason Butler, Ph.D. is a licensed clinical psychologist, a practicing psychotherapist, writer, and educator. He is a core faculty member at the California Institute of Integral Studies and a therapist with the Multidisciplinary Association for Psychedelic Studies (MAPS) expanded access program using MDMA-assisted psychotherapy for PTSD. He is a co-founder of Sage Institute, a clinic in Oakland offering low fee ketamine-assisted psychotherapy and trauma-focused psychotherapy. He has written several articles and book chapters focused on the intersection of depth psychology and social justice as well as a book entitled Archetypal Psychotherapy: The Clinical Legacy of James Hillman. He is the editor of a forthcoming volume on psychedelic-assisted psychotherapy, to be published in Spring 2023.

Genesee Herzberg, Psy.D. is a clinical psychologist offering psychotherapy and ketamine assisted therapy in Berkeley, CA. She is also a co-therapist for the MAPS MDMA-assisted therapy for PTSD program. In 2018, Genesee co-founded Sage Integrative Health, a holistic psychedelic clinic, and a year later she co-founded its sister nonprofit, Sage Institute, a low fee psychedelic clinic and internship training center. Genesee develops curriculum and offers training in ketamine-assisted therapy through Sage and MDMA-assisted therapy through MAPS. Genesee is passionate about making psychedelic medicine accessible to everyone who can benefit. When not wearing one of her many hats in the psychedelic field, Genesee can be found on meandering walks in the Berkeley hills, exploring the far reaches of consciousness, or working on an edited book on psychedelic assisted therapy.

Karen Peoples, Ph.D. is a Personal/Supervising Analyst and Faculty at the Psychoanalytic Institute of Northern California, and Faculty at the San Francisco Center for Psychoanalysis. She served as a Sub-Investigator and Therapist on the Multidisciplinary Association for Psychedelic Studies (MAPS) Phase 3 clinical trial for treatment-resistant PTSD at UCSF, and is currently an Associate Supervisor in MAPS' Expanded Access and European Clinical Trials. She is a psychologist/psychoanalyst in private practice in the San Francisco Bay Area. Karen has published and presented numerous analytic papers on the uncanny and altered states of consciousness, including the value of a psychoanalytic perspective in psychedelic-assisted therapy. Karen has a long-standing interest in contemplative traditions and practices.

Evan Sola, Psy.D. Evan Sola is a licensed psychologist in California, with a private practice in Oakland. He is a researcher for MAPS in FDA clinical trials for MDMA-Assisted therapy for severe PTSD at UCSF, and provides training and supervision for MAPS as they scale up for FDA approval. Evan did his postdoctoral training at Access Institute, in the child track, and continues to see children and adults in his practice.

Share with friends